4
Changes in Ownership
Beam Therapeutics Inc. Filed Acc 0000950170-24-041432
CEO sold 18,102 shares at $32.13 ($581,617)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Evans John M. CEO | 2024-04-01 | Sale 10b5-1 | −18,102 | $32.13 | $581,617 | 1,058,343 | D |
| Derivatives | |||||||
| Evans John M. CEO | 2024-04-03 | Grant or award · Stock Option (Right to Buy) 10b5-1 | +99,336 | 99,336 | D | ||
| Evans John M. CEO | 2024-04-03 | Grant or award · Stock Option (Right to Buy) 10b5-1 | +53,965 | 53,965 | D | ||
| Open-market sales · 18,102 sh · avg $32.13 · $581,617 | |||||||
Loading xslF345X05/ownership.xml…